Request Demo
Last update 20 Mar 2025
Recombinant human interleukin-2, 125Ala(Beijing SL Pharmaceutical Co., Ltd.)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Interleukins |
Synonyms IL-2 (Beijing SL Pharmaceutical), Xin Ji Er, 欣吉尔 |
Target |
Action modulators |
Mechanism IL-2R modulators(Interleukin-2 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1999), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant human interleukin-2, 125Ala(Beijing SL Pharmaceutical Co., Ltd.)NCT06504875
Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer: A Single-center, Single-arm, Open-label Clinical Study (PICTURE)
100 Clinical Results associated with Recombinant human interleukin-2, 125Ala(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant human interleukin-2, 125Ala(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant human interleukin-2, 125Ala(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
100 Deals associated with Recombinant human interleukin-2, 125Ala(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Ascites | China | 01 Jan 1999 | |
| Infectious Diseases | China | 01 Jan 1999 | |
| Lung Cancer | China | 01 Jan 1999 | |
| Lymphoma | China | 01 Jan 1999 | |
| Melanoma | China | 01 Jan 1999 | |
| Rheumatoid Arthritis | China | 01 Jan 1999 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free